General de Mostoles Hospital Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2010
NCT01091675
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

H. F. ALCORCÓN

Active Ingredients

Drugs in Phase 4 Trials (1)

levobupivacaine (chirocaine) (1 trial)

Drugs in Phase 3 Trials (1)

etoricoxib (Gencox) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Spondylitis (Phase 3)

Spondylitis, Ankylosing (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2